featured
Cannabis and Cannabinoids for Symptomatic Treatment in People With MS
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Cochrane Database of Systematic Reviews
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Cannabis and cannabinoids for symptomatic treatment for people with multiple sclerosis
Cochrane Database Syst Rev 2022 May 05;5(2022)CD013444, G Filippini, S Minozzi, F Borrelli, M Cinquini, K DwanFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.